semaglutide cardiovascular outcomes trial Full SELECT Results Affirm CV Risk Reduction With in Nondiabetics π¨ Breaking News: Real-World Data
Description
BMJ Open Diabetes Research & Care
If you're using oral semaglutide (rather than injections), timing becomes slightly more important
This reframes eating as purposeful and goal-oriented, which tends to be more motivating than counting net calories on days when appetite is absent
Expected weight change: Continued loss of 1 to 2.5 pounds per week
Finished my first month and feeling good
However, Wegovy does not mimic GIP
